Weil Company’s Tenet Healthcare THC Stock Holding History

Weil Company’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-325	Closed	-$7K	–	304
2019 Q3	$7K	Buy	+325	New	+$6.92K	0.01%	319

Other funds holding THC

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

CCP

Cyrus Capital Partners New York $196M AUM 123.68% 1-Year Est. Return

Weil Company's THC Position: Q4 2019 in Review

Weil Company sold out of Tenet Healthcare (THC) in Q4 2019, closing a stake of 325 shares — an estimated $7K sold.

Weil Company first reported a position in THC in Q3 2019 and held it in 1 quarter. The position peaked at $7K in Q3 2019. 265 funds tracked by Wall St. Rank hold THC as of Q4 2019.

Weil Company reported no remaining Tenet Healthcare position as of Q4 2019 after selling out during the quarter.
Weil Company sold 325 Tenet Healthcare shares in Q4 2019, an estimated $7K.
Weil Company first reported a position in Tenet Healthcare in Q3 2019 and held it in 1 quarter.
Weil Company's Tenet Healthcare position peaked at $7K in Q3 2019.
265 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.